By introducing molecular indicator, CK19/GPC3 and AFP, the model showed significantly improved recurrence stratification of these patients who met the major HCC staging systems, including MC, UCSF, Fudan and Hangzhou criteria. Here, KRT19 is linked to hepatocellular carcinoma.